Sandhill-Medovations merger to operate as Diversatek Healthcare | Offering pulls in $8.2M for Delphinus | DePuy Synthes announces acquisition of TRS' 3D tech
April 21, 2017
ADVAMED SmartBrief
News for medical technology professionals
SIGN UP ⋅   FORWARD
Top Story
Sandhill-Medovations merger to operate as Diversatek Healthcare
A merger has been announced between Sandhill Scientific and Medovations, both owned by Diversatek, through which they will operate as a single organization named Diversatek Healthcare. Through the merger, Sandhill's diagnostic solutions for esophageal motility disorders, gastroesophageal reflux disease and anorectal motility disorders will be combined with Medovations' portfolio of endoscopy products.
MassDevice.com (Boston) (4/20) 
LinkedIn Twitter Facebook Google+ Email
Business & Market Trends
Offering pulls in $8.2M for Delphinus
A mixed shelf offering involving nine unnamed investors has brought in $8.2 million for Novi, Mich.-based Delphinus Medical Technologies, according to a filing with the SEC. The company, which makes the SoftVue whole breast ultrasound system, did not disclose how it intends to use the proceeds and is still looking to raise $16.8 million in the round.
MassDevice.com (Boston) (4/20) 
LinkedIn Twitter Facebook Google+ Email
DePuy Synthes announces acquisition of TRS' 3D tech
Tissue Regeneration System's 3D technology has been acquired by Johnson & Johnson unit DePuy Synthes in a move that is expected to bolster the company's trauma platform. Using TRS' 3D-printing methods, DePuy will be able to enhance its ability to develop patient-specific, unique mineral-coated bioresorbable implants for promoting bone healing in patients with craniomaxillofacial and orthopedic deformities and injuries.
BeckersSpine.com (4/20) 
LinkedIn Twitter Facebook Google+ Email
Cellnovo, TypeZero reach systems integration deal
TypeZero Technologies has signed a nonexclusive agreement giving Cellnovo a commercial license to integrate its artificial pancreas software, inControl AP, into Cellnovo's all-in-one, mobile insulin pump system. The deal, for which terms were undisclosed, allows Cellnovo to globally commercialize a Cellnovo-TypeZero product, with the integrated product expected to be launched next year.
Medtech Insight (free registration) (4/20) 
LinkedIn Twitter Facebook Google+ Email
Report predicts growth for European biliary, pancreatic stents market
A GlobalData report predicts the European market for pancreatic and biliary stents will reach about $84 million by 2023 with a 4.8% compound annual growth rate because of the development of stenting technology and higher cancer rates. Boston Scientific and Cook Medical are the leading market players.
The Economic Times (India) (4/20) 
LinkedIn Twitter Facebook Google+ Email
Science & Health
Study launched by Illumina spinout for early breast cancer detection
The STRIVE trial, a longitudinal, prospective, observational study, has been launched by Illumina spinout Grail in hopes of developing and validating a next-generation sequencing-based blood test for detecting early-stage breast cancer. The multicenter study will include up to 120,000 women receiving routine mammograms throughout the Sutter Health system in Northern California and at the Mayo Clinic.
MedCityNews.com (4/20),  GenomeWeb Daily News (free registration) (4/20) 
LinkedIn Twitter Facebook Google+ Email
Emerging Technologies
Cardiac Insight's wearable ECG sensor wins FDA clearance
Cardiac Insight has obtained clearance from the FDA for its single-use, leadless, wearable electrocardiogram sensor, Cardeo Solo. The water-resistant, disposable device, which can be worn for up to a week, stores information on patient symptoms and ECG data and allows for real-time analysis of cardiac data with tandem software.
eMPR.com (4/20) 
LinkedIn Twitter Facebook Google+ Email
Government & Regulatory
Halyard's thermal treatment for osteoarthritis knee pain cleared by FDA
The FDA has granted Halyard Health clearance to market its Coolief cooled radiofrequency thermal treatment for relieving chronic moderate to severe osteoarthritis pain in the knee. The minimally invasive, thermal radiofrequency pain management system safely deactivates sensory nerves that cause pain using water-cooled technology.
FDAnews (4/21) 
LinkedIn Twitter Facebook Google+ Email
FDA clears Life Spine's cervical spacer system
The FDA has given Illinois-based Life Spine clearance to market its Plateau-C Ti cervical spacer system, which comes with OSSEO-LOC titanium surface technology to support potential bone growth. The system promotes increased visibility in situ and bone graft containment by providing additional graft windows.
FDAnews (4/20) 
LinkedIn Twitter Facebook Google+ Email
Recall of Medtronic's StrataMR valves, shunts labeled Class I by FDA
A recall initiated by Medtronic involving nearly 2,000 StrataMR adjustable valves and shunts has been classified by the FDA as Class I. The recall was issued because a design flaw may lead to underdrainage of cerebrospinal fluid, posing the risks of headaches, vomiting, nausea, coma and death.
Medtech Insight (free registration) (4/20) 
LinkedIn Twitter Facebook Google+ Email
AdvaMed Events and Education
Medical Device Complaints, MDRs & Reports Workshop
May 23-24 | Washington, D.C.
How do you implement and measure the effectiveness of a complaint-handling system covering a diverse set of possible products and problems? How are complaint files managed across multiple domestic and international facilities? When do complaints rise to the level of MDRs, and how do you handle recalls? What are the current FDA enforcement trends in these areas? Industry experts and FDA staff will explore these issues during this two-day workshop. Learn more.
LinkedIn Twitter Facebook Google+ Email
Start saving with the AdvaMed Purchasing Group
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.
LinkedIn Twitter Facebook Google+ Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
Press Releases
Post a Press Release
JOBS
powered by
Business Analyst, Third Party Compliance
BOSTON SCIENTIFIC - Marlborough, MA
Compliance & Data Protection Officer - Telford, PA
DRAEGER - Telford, PA
Director of Regulatory Affairs and Quality Assurance
BAY LABS, INC. - San Francisco, CA
• Sr Manager, Market Access & Reimbursement Strategy – Transcatheter Mitral and Tricuspid Technologi
EDWARDS LIFESCIENCES - Irvine, CA
Manager, Market Access & Reimbursement Strategy – Transcatheter Mitral and Tricuspid Technologies
EDWARDS LIFESCIENCES - Irvine, CA
  
  
I stand upon my desk to remind myself that we must constantly look at things in a different way.
Tom Schulman,
screenwriter
LinkedIn Twitter Facebook Google+ Email
  
  
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Christopher Black
Jobs Contact  -  jobhelp@smartbrief.com
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information